DANYEL PARKER: Open Payments
NPI 1184147068 · BRYAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 11 payments from 8 companies in 2025. Trend: 2023 $107 · 2024 $201 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Braeburn Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: Auvelity, CAPLYTA, INGREZZA, BRIXADI, ARISTADA, AUSTEDO XR, HETLIOZ, VRAYLAR.
Industry payments across OH — which companies pay providers there.
